Shiliang Li

Title: Shiliang Li: Innovator in Pharmaceutical Compounds

Introduction

Shiliang Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating hypertension and related diseases. With a total of two patents to his name, his work showcases innovative approaches to drug development.

Latest Patents

Li's latest patents include an antihypertensive polyol compound and a derivative thereof. This invention provides a compound that can be used for preparing drugs aimed at preventing or treating hypertension and pulmonary hypertension. The unique mechanism of action of this compound distinguishes it from existing treatments, offering a new foundation for drug development in this area.

Another notable patent is related to six-membered ring benzo derivatives as DPP-4 inhibitors. This invention focuses on a specific compound that can be utilized in pharmaceutical compositions for treating DPP-4 related diseases. The implications of this work are significant for the advancement of diabetes treatments.

Career Highlights

Throughout his career, Shiliang Li has worked with notable organizations, including Tao Pharmaceutical (Suzhou) Co. Ltd and East China University of Science and Technology. His experience in these institutions has allowed him to collaborate on various innovative projects and contribute to the advancement of pharmaceutical sciences.

Collaborations

Li has collaborated with several professionals in his field, including Honglin Li and Zhenjiang Zhao. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Shiliang Li's contributions to pharmaceutical innovation are noteworthy, particularly in the development of compounds for treating hypertension and DPP-4 related diseases. His work exemplifies the importance of innovation in the medical field, paving the way for new therapeutic options.